Treatment Set TS351201 - Treatment Set TS351201

Navigation: NDC > Supplier starting with: A > ANTIGEN LABORATORIES, INC.

Field	Value
NDC Code:	49288-0955
Proprietary Name:	Treatment Set TS351201
Suffix:
Non-Proprietary Name:	Treatment Set TS351201
Dosage Form:	INJECTION, SOLUTION
Method:	INTRADERMAL; SUBCUTANEOUS
Original Marketing Date:	31-10-1986
Category Name:	BLA
Application Number:	BLA102223
Labeler:	ANTIGEN LABORATORIES, INC.
Substance Name:	ALTERNARIA ALTERNATA; AVENA SATIVA POLLEN; COCHLIOBOLUS SATIVUS; CYNODON DACTYLON POLLEN; DERMATOPHAGOIDES PTERONYSSINUS; PASCOPYRUM SMITHII POLLEN; PHLEUM PRATENSE POLLEN; SORGHUM HALEPENSE POLLEN
Active Numerator Strength:	.01; .002; .01; 400; 2000; .002; 4000; .002
Active Ingredient Unit:	g/mL; g/mL; g/mL; [BAU]/mL; [AU]/mL; g/mL; [BAU]/mL; g/mL
Pharm Classes:	Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]
DEA Schedule: